Min-Yue Zhang, Fei Xiao, Zi-Hua Li, Hong-Hui Huang. Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens. // Cancer Cell International. – 2026. – DOI: 10.1186/s12935-026-04293-4. – URL: https://doi.org/10.1186/s12935-026-04293-4
Min-Yue Zhang, Fei Xiao, Zi-Hua Li, & Hong-Hui Huang (2026). Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens. Cancer Cell International. https://doi.org/10.1186/s12935-026-04293-4
Min-Yue Zhang, et al. “Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens.” Cancer Cell International, 2026. doi:10.1186/s12935-026-04293-4.
@article{Zhang2026,
title = {Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens},
author = {Zhang, Min-Yue and Xiao, Fei and Li, Zi-Hua and Huang, Hong-Hui},
journal = {Cancer Cell International},
year = {2026},
doi = {10.1186/s12935-026-04293-4},
url = {https://doi.org/10.1186/s12935-026-04293-4}
}